Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | STAT3 | P40763 | 6/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Asperulosidic Acid SCHEMBL29459346 | 1.00 | MAPT (0.52) | MAPTL3MBTL1MEN1KMT2AELANE | |
| SCHEMBL9057631 | 0.90 | ELANE (0.55) | MAPTL3MBTL1MEN1KMT2AELANE | |
| SCHEMBL29425998 | 0.90 | ELANE (0.46) | MAPTL3MBTL1MEN1KMT2AELANE | |
| Paederosidic Acid SCHEMBL424808 | 0.90 | MAPT (0.50) | MAPTL3MBTL1MEN1KMT2AELANE | |
| Scandoside SCHEMBL29426072 | 0.88 | L3MBTL1 (0.61) | MAPTL3MBTL1MEN1KMT2AELANE | |
| Scandoside SCHEMBL307654 | 0.88 | L3MBTL1 (0.61) | MAPTL3MBTL1MEN1KMT2AELANE | |
| Scandoside SCHEMBL29682452 | 0.88 | L3MBTL1 (0.61) | MAPTL3MBTL1MEN1KMT2AELANE | |
| SCHEMBL31228947 | 0.84 | PTPN1 (0.57) | MAPTPTPN1 | |
| SCHEMBL424407 | 0.83 | MAPT (0.44) | MAPTL3MBTL1MEN1KMT2AELANE | |
| SCHEMBL29425962 | 0.83 | L3MBTL1 (0.53) | MAPTL3MBTL1MEN1KMT2AELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115334909-B | Food composition for preventing and improving diabetes comprising fermented noni and method for producing the same | NST生物股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-115245533-B | Application of Nanshan flower root extract in treating pulmonary fibrosis | 中国医学科学院药物研究所 | 2023-07-28 | — | — | CN | claimed |
| US-11628195-B2 | Method for preparing iridoid-rich noni fruit extract or fraction thereof, method for preparing immune-enhancing active material-rich noni fruit extract or fraction thereof and use of noni fruit extract or fraction thereof | COSMAX NBT, INC. (KR) | 2023-04-18 | — | — | US | claimed |
| CN-115728404-A | Lanqin oral liquid contrast extract and preparation method and application thereof | 扬子江药业集团有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-115684427-A | Fingerprint detection method of Fushou capsule, comparison fingerprint and application | 厦门中药厂有限公司 | 2023-02-03 | — | — | CN | claimed |
| US-20220408777-A1 | FOOD COMPOSITION FOR PREVENTING AND AMELIORATING DIABETES COMPRISING FERMENTED NONI AND METHOD FOR PREPARING SAME | NSTBIO. CO., LTD. (KR) | 2022-12-29 | — | — | US | claimed |
| CN-115334909-A | Food composition for preventing and improving diabetes comprising fermented noni and preparation method thereof | NST生物股份有限公司 | 2022-11-11 | — | — | CN | claimed |
| CN-115308331-A | Method for determining content of 5 components in standard oldenlandia diffusa decoction freeze-dried powder or formula granules by adopting one-test-multiple evaluation method | 山东宏济堂制药集团股份有限公司 | 2022-11-08 | — | — | CN | claimed |
| WO-2022228095-A1 | APPLICATION OF PRISMATOMERIS CONNATA Y. Z. RUAN ROOT EXTRACT IN PREPARATION OF MEDICINE FOR TREATING PULMONARY FIBROSIS | 中国医学科学院药物研究所 | 2022-11-03 | — | — | WO | claimed |
| CN-115245533-A | Application of south mountain flower root extract in pulmonary fibrosis treatment | 中国医学科学院药物研究所 | 2022-10-28 | — | — | CN | claimed |
| WO-2011106432-A2 | MORINDA CITRIFOLIA AND IRIDOID BASED FORMULATIONS | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2011-09-01 | — | — | WO | claimed |
| WO-2011106423-A2 | ACAI AND IRIDOID BASED FORMULATIONS | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2011-09-01 | — | — | WO | claimed |
| US-20110206786-A1 | Acai and Iridoid Based Formulations | TAHITIAN NONI INTERNATIONAL, INC. | 2011-08-25 | — | — | US | claimed |
| US-20110206787-A1 | Morinda Citrifolia and Iridoid Based Formulations | MORINDA, INC. | 2011-08-25 | — | — | US | claimed |
| CN-101336983-B | Oldenlandia and quality control method of preparation containing oldenlandia | GUANGXI ZHUANG NATIONALITY AUTONOMOUS REGION HUAHONG PHARMACEUTICAL CO LTD | 2011-07-27 | — | — | CN | claimed |
| WO-2010030000-A1 | SKIN-WHITENING AGENT AND EXTERNAL SKIN PREPARATION FOR WHITENING OF SKIN | 学校法人 日本大学 (JP) | 2010-03-18 | — | — | WO | claimed |
| CN-101496845-A | Hedyotis diffusa Willd. extract and method for separating and preparing the same | DALIAN CHEMICAL PHYSICS INST (CN) | 2009-08-05 | — | — | CN | claimed |
| CN-101336983-A | Oldenlandia and quality control method of preparation containing oldenlandia | GUANGXI AUTONOMOUS REGION HUAH (CN) | 2009-01-07 | — | — | CN | claimed |
| CN-101085794-A | Method for preparing 10-deacetyl asperulosidic acid methyl ester | GUANGXI HUAHONG PHARMACEUTICAL (CN) | 2007-12-12 | — | — | CN | claimed |
| US-7179287-B2 | Bioreactor mediated recellularization of natural and tissue engineered vascular grafts | BIOSCIENCE CONSULTANTS (US) | 2007-02-20 | — | — | US | claimed |